July 21, 2020 – Acentrus Specialty (Irving, TX), a national network of health systems and hospitals providing specialty pharmacy care for their patients, has agreed with Puma Biotechnology, Inc. to provide qualified Acentrus clients access to NERLYNX (neratinib), a breast cancer treatment. Participation in Acentrus is open to hospital organizations of all sizes, types and … [Read more...]